Literature DB >> 26588351

Metabolic Syndrome: Bridging the Gap from Childhood to Adulthood.

Mehmet Agirbasli1, Azra M Tanrikulu2, Gerald S Berenson3.   

Abstract

Childhood and adolescence are particularly vulnerable periods of life to the effects of cardiometabolic risk and later development of atherosclerosis, hypertension, and diabetes mellitus. Developing countries with limited resources suffer most heavily from the consequences of cardiometabolic risk in children and its future implications to the global health burden. A better understanding of mechanisms leading to cardiometabolic risk in early life may lead to more effective prevention and intervention strategies to reduce metabolic stress in children and later disease. Longitudinal "tracking" studies of cardiometabolic risk in children provide a tremendous global resource to direct prevention strategies for cardiovascular disease. In this review, we will summarize the pathophysiology, existing definitions for cardiometabolic risk components in children. Screening and identifying children and adolescents of high cardiometabolic risk and encouraging them and their families through healthy lifestyle changes should be implemented to as a global public health strategy.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Atherosclerosis; Cardiometabolic risk; Children; Lipids disorder; Metabolic syndrome

Mesh:

Year:  2016        PMID: 26588351     DOI: 10.1111/1755-5922.12165

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  23 in total

Review 1.  The initiation of metabolic inflammation in childhood obesity.

Authors:  Kanakadurga Singer; Carey N Lumeng
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Metabolic risk assessment in children and adolescents using the tri-ponderal mass index.

Authors:  Young-Jun Seo; Young Suk Shim; Hae Sang Lee; Jin Soon Hwang
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

3.  SNAP and Cardiometabolic Risk in Youth.

Authors:  Katelin M Alfaro-Hudak; Lisa Schulkind; Elizabeth F Racine; Arthur Zillante
Journal:  Nutrients       Date:  2022-07-02       Impact factor: 6.706

4.  Prevalence of Metabolic Syndrome and its Associated Risk Factors in Pediatric Obesity.

Authors:  Wan Muhammad Najib Wan Mahmud Sabri; Rashdan Zaki Mohamed; Najib Majdi Yaacob; Suhaimi Hussain
Journal:  J ASEAN Fed Endocr Soc       Date:  2022-04-29

5.  Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice.

Authors:  Annayya R Aroor; Guanghong Jia; Javad Habibi; Zhe Sun; Francisco I Ramirez-Perez; Barron Brady; Dongqing Chen; Luis A Martinez-Lemus; Camila Manrique; Ravi Nistala; Adam T Whaley-Connell; Vincent G Demarco; Gerald A Meininger; James R Sowers
Journal:  Metabolism       Date:  2017-06-21       Impact factor: 8.694

Review 6.  Diabetes Mellitus, Arterial Wall, and Cardiovascular Risk Assessment.

Authors:  Michaela Kozakova; Carlo Palombo
Journal:  Int J Environ Res Public Health       Date:  2016-02-06       Impact factor: 3.390

7.  A Critical Examination of the Use of Trained Health Coaches to Decrease the Metabolic Syndrome for Participants of a Community-Based Diabetes Prevention and Management Program.

Authors:  Brandon Lucke-Wold; Samantha Shawley; John Spencer Ingels; Jonathan Stewart; Ranjita Misra
Journal:  J Healthc Commun       Date:  2016-11-01

8.  Metabolic syndrome's risk factors and its association with nutritional status in schoolchildren.

Authors:  Fabiana Costa Teixeira; Flavia Erika Felix Pereira; Avany Fernandes Pereira; Beatriz Gonçalves Ribeiro
Journal:  Prev Med Rep       Date:  2017-02-08

9.  Anthropometric features as predictors of atherogenic dyslipidemia and cardiovascular risk in a large population of school-aged children.

Authors:  José M Furtado; Sílvia M Almeida; Paulo Mascarenhas; Maria E Ferraz; José C Ferreira; Manuel Vilanova; Mariana P Monteiro; Fernando P Ferraz
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

10.  Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes.

Authors:  Annayya R Aroor; Adam Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.